Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares saw unusually-high trading volume on Friday . Approximately 15,000 shares changed hands during mid-day trading, an increase of 111% from the previous session’s volume of 7,110 shares.The stock last traded at $8.10 and had previously closed at $8.25.
Oxford BioMedica Trading Down 1.8%
The stock’s 50-day simple moving average is $8.35 and its 200-day simple moving average is $6.99. The company has a current ratio of 1.89, a quick ratio of 1.67 and a debt-to-equity ratio of 3.08.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
See Also
- Five stocks we like better than Oxford BioMedica
- Washington prepares for war
- Do you know what Amazon is planning for January 1?
- Nvidia x 1,000,000
- Wall Street Stockpicker Names #1 Stock of 2026
- The McDonald’s Secret
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
